FRANKFURT — Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and ...
TRAILBLAZER-2, a Phase 3 study, has enrolled 1,600 participants. Prescreening with plasma p-tau-181 helped select people with both amyloid and tau pathology. A secondary prevention trial, ...
LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global three-phase separator market in the oil and gas industry report. This research report also lists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results